Zacks Investment ResearchMon, 04 May 2026 15:00:29 GMTAnalysts Estimate Heron Therapeutics (HRTX) to Report a Decline in Earnings: What to Look Out forHRTX-2.42%
Seeking AlphaThu, 26 Feb 2026 20:08:38 GMTHeron Therapeutics, Inc. (HRTX) Q4 2025 Earnings Call TranscriptHRTX-2.42%
Zacks Investment ResearchThu, 26 Feb 2026 18:30:36 GMTHeron Therapeutics (HRTX) Reports Q4 Earnings: What Key Metrics Have to SayHRTX-2.42%
Seeking AlphaWed, 18 Feb 2026 15:28:56 GMTHeron: Near The Bottom Of A Trading Range Despite PositivesHRTX-2.42%